Biomedical and life sciences include sub-biotechnologies from pharmaceuticals, medical devices and digital health sectors.
This industry benefit both in France and Israel from excellence in academic research, deep government support, highly educated professionals, innovative spirit and great technologies.
It is one of the main thematic where Israel and France have already built in the past very strong ties and lead to strong joint industrial projects and commercial outcomes.
As part of our 2020 Action Plan and in close coordination with Bpifrance and the Israel Innovation Authority, we are promoting the R&D partnerships between France and Israel through the EUROSTARS program.
The next cut-off is planned on February 13, 2020.
